Suffering, Science and Sabotage

REFERENCES

• Yunus M B. Research in fibromyalgia and myofascial pain syndromes: current status, problems and future directions. J Musculoskeletal Pain 1993; 1: 23–4
   Google Scholar
• Cassell E J. The Nature of Suffering. Oxford University Press, Oxford 1991
   Google Scholar
• Depressed? Read Abraham Lincoln's Words. 2003, http://home.att.net/~rjnorton/Lincoln84.html 10–16-
   Google Scholar
• Van Hooft S. Suffering and the goals of medicine. Med Health Care Philos 1998; 1: 125–131
   PubMedGoogle Scholar
• Gunderman R B. Is suffering the enemy?. Hastings Cent Rep 2002; 32: 40–44
   PubMed Web of Science ®Google Scholar
• Edwards S D. Three concepts of suffering. Med. Health Care Philos. 2003; 6: 59–66
   PubMedGoogle Scholar
• Zubieta J K, Heitzeg M M, Smith Y R, Bueller J A, Xu K, Xu Y, Koeppe R A, Stohler C S, Goldman D. COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science 2003; 299: 1240–1243
   PubMed Web of Science ®Google Scholar
• Coghill R C, McHaffie J G, Yen Y F. Neural correlates of interindividual differences in the subjective experience of pain:. Proc Natl Acad Sci USA. 2003; 100: 8538–8542
   PubMed Web of Science ®Google Scholar
• Gracely R H, Petzke F, Wolf J M, Clauw D J. Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum 2003; 46: 1333–1343
   Google Scholar
• Spiro H. What is empathy and can it be taught?. Ann Intern Med 1992; 116: 843–846
   PubMed Web of Science ®Google Scholar
• Mirowsky J, Ross C E. Measurement for a human science. J Health Soc Behav 2002; 43: 152–170
   PubMed Web of Science ®Google Scholar
• Finckh A, Iversen M, Liang M H. The exercise prescription in rheumatoid arthritis: Primum non nocere. Arthritis Rheum 2003; 48: 2393–2395
   PubMed Web of Science ®Google Scholar
• Menninger R W. Psychiatry 1976: Time for a holistic medicine. Ann. Intern. Med. 1976; 84: 603–604
   PubMed Web of Science ®Google Scholar
• Engel G L. The need for a new medical model: A challenge for biomedicine. Science 1977; 196: 129–136
   PubMed Web of Science ®Google Scholar
• Masi A T. An holistic concept of health and illness: A tricentennial goal for medicine and public health. J Chronic Dis 1978; 31: 563–572
   PubMedGoogle Scholar
• Donnelly G F. Integrate holistic care one patient at a time. Holist Nurs Pract 2003; 17, 117
   Google Scholar
• Pal M N. Philosophy of medicine according to Ayurveda. Bull Indian Inst Hist Med Hyderabad 1997; 27: 103–118
   PubMedGoogle Scholar
• Yunus M B. Central sensitivity syndromes: A unified concept for fibromyalgia and other similar maladies. JIRA 2000; 8: 27–33
   Google Scholar
• Yunus M B, Inanici F. Clinical characteristics and biopathophysiological mechanisms of fibromyalgia syndromes Myofascial Pain and Fibromyalgia syndromes, P E Baldry, 2001; 351–377
   Google Scholar
• Bohr T W. Fibromyalgia syndrome and myofascial pain syndrome. Do they exist?. Neurol Clin 1995; 13: 365–384
   PubMed Web of Science ®Google Scholar
• Ehrlich G E. Fibromyalgia, a virtual disease. Clin. Rheumatol 2003; 22: 8–11
   Web of Science ®Google Scholar
• Ehrlich G E. Pain is real; fibromyalgia isn't. J Rheumatol 2003; 30: 1666–1667
   PubMed Web of Science ®Google Scholar
• Hadler N M. Fibromyalgia, chronic fatigue, and other iatrogenic diagnostic algorithms. Do some labels escalate illness in vulnerable patients?. Postgrad Med 1997; 102: 161–177
   PubMed Web of Science ®Google Scholar
• Hadler N M. “Fibromyalgia” and the medicalization of misery. J Rheumatol 2003; 30: 1668–1670
   PubMed Web of Science ®Google Scholar
• Ford C V. Somatization and fashionable diagnoses: Illness as a way of life. Scan J Work Environ Health 23 Suppl: 1997; 3: 7–16
   Google Scholar
• Yunus M B, Masi A T, Aldag J CA. A controlled study of primary fibromyalgia syndrome: Clinical features and associations with other functional syndromes. J Rheumatol suppl 1989; 19: 62–71
   PubMedGoogle Scholar
• Yunus M B. Psychological aspects of fibromyalgia syndrome: A component of the dysfunctional spectrum syndrome. Baillieres Clin Rheumatol 1994; 8: 811–837
   PubMed Web of Science ®Google Scholar
• Yunus M B, Aldag J C, Frye A. Subgrouping of fibromyalgia syndrome (FMS) by clustering technique. Arthritis Rheum 2003; 48: S503
   Google Scholar
• Masi A T, White K P, Pilcher J J. Person-centered approach to care, teaching, and research in fibromyalgia syndrome: Justification from biopsychosocial perspectives in populations. Semin Arthritis Rheum 2002; 32: 71–93
   PubMed Web of Science ®Google Scholar
• Giesecke T, Williams D A, Harris R E, Cupps T R, Tian X, Tian T X, Gracely R H, Clauw D J. Subgrouping of fibromyalgia patients on the basis of pressure-pain thresholds and psychological factors. Arthritis Rheum 2003; 48: 2916–2922
   PubMed Web of Science ®Google Scholar
• Russell I J. Advances in fibromyalgia: Possible role for central neurochemicals. Am J Med Sci 1998; 315: 377–384
   PubMed Web of Science ®Google Scholar
• Neeck G, Crofford L J. Neuroendocrine perturbations in fibromyalgia and chronic fatigue syndrome. Rheum Dis Clin North Am 2000; 26: 989–1002
   PubMed Web of Science ®Google Scholar
• Crofford L J, Pillemer S R, Kalogeras K T, Cash J M, Michelson D, Kling M A, Sternberg E M, Gold P W, Chrousos G P, Wilder R L. Hypothalamic-pituitary-ad-renal axis perturbations in patients with fibromyalgia. Arthritis Rheum 1994; 37: 1583–1592
   PubMed Web of Science ®Google Scholar
• Bendtsen L, Jensen R, Olesen J. Decreased pain detection and tolerance thresholds in chronic tension-type headache. Arch Neurol 1996; 53: 373–376
   PubMed Web of Science ®Google Scholar
• Cleare A J. The neuroendocrinology of chronic fatigue syndrome. Endocr Rev 2003; 24: 236–252
   PubMed Web of Science ®Google Scholar
• Vecchiet L, Montanari G, Pizzigallo E, Iezzi S, de Bigontina P, Dragani L, Vecchiet J, Giamberardino M A. Sensory characterization of somatic parietal tissues in humans with chronic fatigue syndrome. Neurosci Lett 1996; 208: 117–120
   PubMed Web of Science ®Google Scholar
• Arendt-Nielsen L, Graven-Nielsen T. Central sensitization in fibromyalgia and other musculoskeletal disorders. Curr Pain Headache Rep 2003; 7: 355–361
   PubMedGoogle Scholar
• Smythe H A, Moldofsky H. Two contributions to understanding of the “fibrositis” syndrome. Bull Rheum Dis 1977; 28: 928–931
   PubMedGoogle Scholar
• Yunus M B, Masi A T, Calabro J J, Miller K A, Feigenbaum S L. Primary fibromyalgia (fibrositis): Clinical study of 50 patients with matched normal controls. Semin Arthritis Rheum 1981; 11: 151–171
   PubMed Web of Science ®Google Scholar
• Vlaeyen J W, Teeken-Gruben N J, Goossens M E, Rutten-van Molken M P, Pelt R A, van Eek H, Heuts P H. Cognitive-educational treatment of fibromyalgia: A randomized clinical trial. I. Clinical effects. J Rheumatol 1996; 23: 1237–1245
   PubMed Web of Science ®Google Scholar
• Nicassio P M, Radojevic V, Weisman M H, Schuman C, Kim J, Schoenfeld-Smith K, Krall T. A comparison of behavioral and educational interventions for fibromyalgia. J Rheumatol 1997; 24: 2000–2007
   PubMed Web of Science ®Google Scholar
• Williams D A, Cary M A, Groner K H, Chaplin W, Glazer L J, Rodriguez A M, Clauw D J. Improving physical functional status in patients with fibromyalgia: A brief cognitive behavioral intervention. J Rheumatol 2002; 29: 1280–1286
   PubMed Web of Science ®Google Scholar
• Etziony M B. The Physician's Creed. Charles C. Thomas, SpringfieldIllinois 1973; 16
   Google Scholar
• Barondess J A. Disease and illness—A crucial distinction. Am J Med 1979; 66: 375–376
   PubMed Web of Science ®Google Scholar
• Jennings D. The confusion between disease and illness in clinical medicine. CMAJ 1986; 135: 865–870
   PubMed Web of Science ®Google Scholar
• Masi A T. An intuitive person-centred perspective on fibromyalgia syndrome and its management. Baillieres Clin. Rheumatol 1994; 8: 957–993
   PubMed Web of Science ®Google Scholar
• Van Houdenhove B. Fibromyalgia: A challenge for modern medicine. Clin. Rheumatol 2003; 22: 1–5
   Web of Science ®Google Scholar
• Esterson A. The leaves of spring: A study in the dialectics of madness. Inter-experience and interaction. Penguin, Harmondsworth, England, Part II 1972; 213–298
   Google Scholar
• Katon W J, Buchwald D S, Simon G E, Russo J E, Mease P J. Psychiatric illness in patients with chronic fatigue and those with rheumatoid arthritis. J Gen Intern Med 1991; 6: 277–285
   PubMed Web of Science ®Google Scholar
• Creed F, Guthrie E. Psychological factors in the irritable bowel syndrome. Gut 1987; 28: 1307–1318
   PubMed Web of Science ®Google Scholar
• Hawley D J, Wolfe F. Pain, disability, and pain/disability relationships in seven rheumatic disorders: A study of 1,522 patients. J Rheumatol 1991; 18: 1552–1557
   PubMed Web of Science ®Google Scholar
• Ahles T A, Khan S A, Yunus M B, Spiegel D A, Masi A T. Psychiatric status of patients with primary fibromyalgia, patients with rheumatoid arthritis, and subjects without pain: A blind comparison of DSM-III diagnoses. Am J Psychiatry 1991; 148: 1721–1726
   PubMed Web of Science ®Google Scholar
• Drossman D A, McKee D C, Sandler R S, Mitchell C M, Cramer E M, Lowman B C, Burger A L. Psychosocial factors in the irritable bowel syndrome. A multi-variate study of patients and nonpatients with irritable bowel syndrome. Gastroenterology 1988; 95: 701–708
   PubMed Web of Science ®Google Scholar
• Aaron L A, Bradley L A, Alarcon G S, Alexander R W, Triana-Alexander M, Martin M Y, Alberts K R. Psychiatric diagnoses in patients with fibromyalgia are related to health care-seeking behavior rather than to illness. Arthritis Rheum 1996; 39: 436–445
   PubMed Web of Science ®Google Scholar
• Lesperance F, Frasure-Smith N, Talajic M, Bourassa M G. Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation 2002; 105: 1049–1053
   PubMed Web of Science ®Google Scholar
• Pratt L A, Ford D E, Crum R M, Armenian H K, Gallo J J, Eaton W W. Depression, psychotropic medication, and risk of myocardial infarction. Prospective data from the Baltimore ECA follow-up. Circulation 1996; 94: 3123–3129
   PubMed Web of Science ®Google Scholar
• Wright G E, Parker J C, Smarr K L, Schoenfeld-Smith K, Buckelew S P, Slaughter J R, Johnson J C, Hewett J E. Risk factors for depression in rheumatoid arthritis. Arthritis Care Res 1996; 9: 264–272
   PubMed Web of Science ®Google Scholar
• Bradley L A. Psychosocial factors and disease outcomes in rheumatoid arthritis: Old problems, new solutions, and a future agenda. Arthritis Rheum 1989; 32: 1611–1614
   PubMed Web of Science ®Google Scholar
• Kozora E, Thompson L L, West S G, Kotzin B L. Analysis of cognitive and psychological deficits in systemic lupus erythematosus patients without overt central nervous system disease. Arthritis Rheum 1996; 39: 2035–2045
   PubMed Web of Science ®Google Scholar
• Hay E M, Black D, Huddy A, Creed F, Tomenson B, Bernstein R M, Holt P J. Psychiatric disorder and cognitive impairment in systemic lupus erythematosus. Arthritis Rheum 1992; 35: 411–416
   PubMed Web of Science ®Google Scholar
• Wells K B, Golding J M, Burnam M A. Affective, substance use, and anxiety disorders in persons with arthritis, diabetes, heart disease, high blood pressure, or chronic lung conditions. Gen Hosp Psychiatry 1989; 11: 320–327
   PubMed Web of Science ®Google Scholar
• Fortune D G, Richards H L, Kirby B, McElhone K, Markham T, Rogers S, Main C J, Griffiths C EM. Psychological distress impairs clearance of psoriasis in patients treated with photochemotherapy. Arch Dermatol 2003; 139: 752–756
   PubMedGoogle Scholar
• Laine C, Davidoff F. Patient-centered medicine. A professional evolution. JAMA 1996; 275: 152–156
   PubMed Web of Science ®Google Scholar
• Ellis S. The patient-centred care model: holistic/ multiprofessional/reflective. Br J Nurs 1999; 8: 296–301
   PubMedGoogle Scholar
• Little P, Everitt H, Williamson I, Warner G, Moore M, Gould C, Ferrier K, Payne S. Observational study of effect of patient centredness and positive approach on outcomes of general practice consultations. BMJ 2001; 323: 908–911
   PubMed Web of Science ®Google Scholar
• Virchow R LK. Die Cellularpathologie in ihrer Begrundung auf physiologische und pathologische Gewebehre. Hirschwald, Berlin 1858
   Google Scholar
• Stedman T L. Stedman's Medical Dictionary. Williams & Wilkins. 1995
   Google Scholar
• Sullivan G M, Coplan J D. Anxiety disorders: Biochemical aspects Kaplan and Sadock's Comprehensive Text Book of Psychiatry, B J Sadock, V A Sadock. Lippincott Williams and Wilkins, Philadelphia 2000; 1450–1490
   Google Scholar
• Thase M E. Mood disorders: Neurobiology Kaplan and Sadock's Coprehensive Textbook of Psychiatry, B J Sadock, V A Sadock. Lippincott, Williams and Wilkins, Philadelphia 2000; 1318–1440
   Google Scholar
• Tsigos C, Chrousos G P. Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosom Res 2002; 53: 865–871
   PubMed Web of Science ®Google Scholar
• Schulkin J, Thompson B L, Rosen J B. Demytholozing the emotions: Adaptation, cognition, and visceral representations of emotion in the nervous system. Brain and Cognition 2003; 52: 15–23
   PubMed Web of Science ®Google Scholar
• Anand A, Shekhar A. Brain imaging studies in mood and anxiety disorders: Special emphasis on the amygdala. Ann N Y Acad Sci 2003; 985: 370–388
   PubMed Web of Science ®Google Scholar
• Post R M. Transduction of psychologic stress into neurobiology of recurrent affective disorder. Am J Psychiatry 1992; 149: 999–1010
   PubMed Web of Science ®Google Scholar
• Arnett F C. Seronegative arthropathies. Bull Rheum Dis 1987; 37: 1–12
   PubMedGoogle Scholar
• Elias A N, Guich S, Wilson A F. Ketosis with enhanced GABAergic tone promotes physiological changes in transcendental meditation. Med Hypotheses 2000; 54: 660–602
   PubMed Web of Science ®Google Scholar
• Yunus M B. Primary fibromyalgia syndrome: Current concepts. Compr Ther 1984; 10: 21–28
   PubMedGoogle Scholar
• Arroyo J F, Cohen M L. Abnormal responses to electrocutaneous stimulation in fibromyalgia. J Rheumatol 1993; 20: 1925–1931
   PubMed Web of Science ®Google Scholar
• Bennett R M. Emerging concepts in the neurobiology of chronic pain: Evidence of abnormal sensory processing in fibromyalgia. Mayo Clin Proc 1999; 74: 385–398
   PubMed Web of Science ®Google Scholar
• Staud R, Vierck C J, Cannon R L, Mauderli A P, Price D D. Abnormal sensitization and temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome. Pain 2001; 91: 165–175
   PubMed Web of Science ®Google Scholar
• Yunus M B, Dailey J W, Aldag J C, Masi A T, Jobe P C. Plasma tryptophan and other amino acids in primary fibromyalgia: A controlled study. J Rheumatol 1992; 19: 90–94
   PubMed Web of Science ®Google Scholar
• Russell I J, Vaeroy H, Javors M, Nyberg F. Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis. Arthritis Rheum 1992; 35: 550–556
   PubMed Web of Science ®Google Scholar
• Hrycaj P, Stratz T, Muller W. Platelet 3H-imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/fibrositis syndrome. J Rheumatol 1993; 20: 1986–1988
   PubMed Web of Science ®Google Scholar
• Bakheit A M, Behan P O, Dinan T G, Gray C E, O'Keane V. Possible upregulation of hypothalamic 5-hydroxytryptamine receptors in patients with post-viral fatigue syndrome. BMJ 1992; 304: 1010–1012
   PubMed Web of Science ®Google Scholar
• Marazziti D, Bonuccelli U, Nuti A, Toni C, Pedri S, Palego L, Pavese N, Lucetti C, Muratorio A, Cassano G B. Platelet 3H-imipramine binding and sulphotrans-ferase activity in primary headache. Cephalalgia 1994; 14: 210–214
   PubMed Web of Science ®Google Scholar
• Russell I J, Orr M D, Littman B, Vipraio G A, Alboukrek D, Michalek J E, Lopez Y, MacKillip F. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum 1994; 37: 1593–1601
   PubMed Web of Science ®Google Scholar
• Nakano T, Shimomura T, Takahashi K, Ikawa S. Platelet substance P and 5-hydroxytryptamine in migraine and tension-type headache. Headache 1993; 33: 528–532
   PubMed Web of Science ®Google Scholar
• Bennett R M. Adult growth hormone deficiency in patients with fibromyalgia. Curr Rheumatol Rep 2002; 4: 306–312
   PubMedGoogle Scholar
• Landis C A, Lentz M J, Rothermel J, Riffle S C, Chapman D, Buchwald D, Shaver J L. Decreased nocturnal levels of prolactin and growth hormone in women with fibromyalgia. J Clin Endocrinol Metab 2001; 86: 1672–1678
   PubMed Web of Science ®Google Scholar
• Moorkens G, Berwaerts J, Wynants H, Abs R. Characterization of pituitary function with emphasis on GH secretion in the chronic fatigue syndrome. Clin. Endocrinol. (Oxf) 2000; 53: 99–106
   PubMed Web of Science ®Google Scholar
• Griep E N, Boersma J W, de Kloet E R. Pituitary release of growth hormone and prolactin in the primary fibromyalgia syndrome. J Rheumatol 1994; 21: 2125–2130
   PubMed Web of Science ®Google Scholar
• Crofford L J, Pillemer S R, Kalogeras K T, Cash J M, Michelson D, Kling M A, Sternberg E M, Gold P W, Chrousos G P, Wilder R L. Hypothalamic-pituitary-ad-renal axis perturbations in patients with fibromyalgia. Arthritis Rheum 1994; 37: 1583–1592
   PubMed Web of Science ®Google Scholar
• Scott L V, Medbak S, Dinan T G. Blunted adrenocorticotropin and cortisol responses to corticotropin-releasing hormone stimulation in chronic fatigue syndrome. Acta Psychiatr Scand 1998; 97: 450–457
   PubMed Web of Science ®Google Scholar
• Demitrack M A, Dale J K, Straus S E, Laue L, Listwak S J, Kruesi M JP, Chrousos G P, Gold P W. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J Clin Endocrinol Metab 1991; 73: 1224–1234
   PubMed Web of Science ®Google Scholar
• Martignoni E, Facchinetti F, Rossi F, Sances G, Genazzani A R, Nappi G. Neuroendocrine evidence of deranged noradrenergic activity in chronic migraine. Psychoneuroendocrinology 1989; 14: 357–363
   PubMed Web of Science ®Google Scholar
• Mountz J M, Bradley L A, Modell J G, Alexander R W, Triana-Alexander M, Aaron L A, Stewart K E, Alarcon G S, Mountz J D. Fibromyalgia in women. Abnormalities of regional cerebral blood flow in the thalamus and the caudate nucleus are associated with low pain threshold levels. Arthritis Rheum 1995; 38: 926–938
   PubMed Web of Science ®Google Scholar
• Kwiatek R, Barnden L, Tedman R, Jarrett R, Chew J, Rowe C, Pile K. Regional cerebral blood flow in fibromyalgia: Single-photon-emission computed tomography evidence of reduction in the pontine tegmentum and thalami. Arthritis Rheum 2000; 43: 2823–2833
   PubMed Web of Science ®Google Scholar
• Abu-Judeh H H, Levine S, Kumar M, el-Zeftawy H, Naddaf S, Lou J Q, Abdel-Dayem H M. Comparison of SPET brain perfusion and 18F-FDG brain metabolism in patients with chronic fatigue syndrome. Nucl Med Commun 1998; 19: 1065–1071
   PubMed Web of Science ®Google Scholar
• Tirelli U, Chierichetti F, Tavio M, Simonelli C, Bianchin G, Zanco P, Ferlin G. Brain positron emission tomography (PET) in chronic fatigue syndrome: Preliminary data. Am J Med 1998; 105: 54S–58S
   PubMedGoogle Scholar
• Yuan Y Z, Tao R J, Xu B, Sun J, Chen K M, Miao F, Zhang Z W, Xu J Y. Functional brain imaging in irritable bowel syndrome with rectal balloon-distention by using fMRI. World J Gastroenterol 2003; 9: 1356–1360
   PubMed Web of Science ®Google Scholar
• Bonaz B, Baciu M, Papillon E, Bost R, Gueddah N, Le Bas J F, Fournet J, Segebarth C. Central processing of rectal pain in patients with irritable bowel syndrome: An fMRI study. Am J Gastroenterol 2002; 97: 654–661
   PubMed Web of Science ®Google Scholar
• Roizenblatt S, Moldofsky H, Benedito-Silva A A, Tufik S. Alpha sleep characteristics in fibromyalgia. Arthritis Rheum 2001; 44: 222–230
   PubMed Web of Science ®Google Scholar
• Offenbacher M, Bondy B, de Jonge S, Glatzeder K, Kruger M, Schoeps P, Ackenheil M. Possible association of fibromyalgia with a polymorphism in the serotonin transporter gene regulatory region. Arthritis Rheum 1999; 42: 2482–2488
   PubMedGoogle Scholar
• Bondy B, Spaeth M, Offenbaecher M, Glatzeder K, Stratz T, Schwarz M, de Jonge S, Kruger M, Engel R R, Farber L, Pongratz D E, Ackenheil M. The T102C polymorphism of the 5-HT2A-receptor gene in fibromyalgia. Neurobiol Dis 1999; 6: 433–439
   PubMed Web of Science ®Google Scholar
• Yunus M B, Khan M A, Rawlings K K, Green J R, Olson J M, Shah S. Genetic linkage analysis of multicase families with fibromyalgia syndrome. J Rheumatol 1999; 26: 408–412
   PubMed Web of Science ®Google Scholar
• Arnold L M, Iyengar S K, Khan M A, Kushner I, Russel I J, Yunus M B, Hess E V, Humphrey J, Reading K, Dudek D M, Olson J M. Genetic linkage of fibromyalgia to the serotonin receptor 2A region on chromosome 13 and the HLA region on chromosome 6. Arthritis Rheum suppl 2003; 48: S228
   Google Scholar
• Buchwald D, Herrell R, Ashton S, Belcourt M, Schmaling K, Sullivan P, Neale M, Goldberg J. A twin study of chronic fatigue. Psychosom Med 2001; 63: 936–943
   PubMed Web of Science ®Google Scholar
• Noble-Topham S E, Cader M Z, Dyment D A, Rice G P, Brown J D, Ebers G C. Genetic loading in familial migraine with aura. J Neurol Neurosurg Psychiatry 2003; 74: 1128–1130
   PubMed Web of Science ®Google Scholar
• Mochi M, Cavoli S, Cortelli P, Pierangeli G, Scapoli C, Soriani S, Montagna P. Investigation of an LDLR gene polymorphism (19p 13.2) in susceptibility to migraine without aura. J Neurol Sci 2003; 213: 7–10
   PubMed Web of Science ®Google Scholar
• Ducros A, Tournier-Lasserve E, Bousser M G. The genetics of migraine. Lancet 2002; 1: 285–293
   Web of Science ®Google Scholar
• Bonati M T, Ferini-Strambi L, Aridon P, Oldani A, Zucconi M, Casari G. Autosomal dominant restless legs syndrome maps on chromosome 14q. Brain 2003; 126: 1485–1492
   PubMed Web of Science ®Google Scholar
• Winkelmann J, Muller-Myhsok B, Wittchen H U, Hock B, Prager M, Pfister H, Strohle A, Eisensehr I, Dichgans M, Gasser T, Trenkwalder C. Complex segregation analysis of restless legs syndrome provides evidence for an autosomal dominant mode of inheritance in early age at onset families. Ann Neurol 2002; 52: 297–302
   PubMed Web of Science ®Google Scholar
• Koc N, Culjkovic B, Maniak S, Schilling K, Muller B, Zuhlke C, Ozelius L, Klein C, Pramstalle P P, Kramer P L. Mode of inheritance and susceptibility locus for restless legs syndrome, on chromosome 12q. Am Hum Genet 2002; 71: 205–208
   PubMed Web of Science ®Google Scholar
• Pata C, Erdal M E, Derici E, Yazar A, Kanik A, Ulu O. Serotonin transporter gene polymorphism in irritable bowel syndrome. Am J Gastroenterol 2002; 97: 1780–1784
   PubMed Web of Science ®Google Scholar
• Wesley S, Hotopf M. Is fibromyalgia a distinct clinical entity? Historical and epidemiological evidence. Baillieres Best Pract Res Clin Rheumatol 1999; 13: 427–436
   PubMed Web of Science ®Google Scholar
• Engel C C, Jr., Adkins J A, Cowan D N. Caring for medically unexplained physical symptoms after toxic environmental exposures: Effects of contested causation. Environ Health Perspect suppl 2002; 4: 641–647
   Google Scholar
• Henningsen P, Zimmermann T, Sattel H. Medically unexplained physical symptoms, anxiety, and depression: A meta-analytic review. Psychosom Med 2003; 65: 528–533
   PubMed Web of Science ®Google Scholar
• McBeth J, Silman A J, Macfarlane G J. Association of widespread pain with increased risk of cancer and reduced cancer survival. Arthritis Rheum 2003; 48: 1686–1692
   PubMed Web of Science ®Google Scholar
• Alamo M M, Moral R R, Perula de Torres L A. Evaluation of a patient-centred approach in generalized musculoskeletal chronic pain/fibromyalgia patients in primary care. Patien Educ Couns 2002; 48: 23–31
   PubMed Web of Science ®Google Scholar
• Wolfe F, Cathey M A, Kleinheksel S M. Fibrositis (Fibromyalgia) in rheumatoid arthritis. J. Rheumatol 1984; 11: 814–818
   Google Scholar
• Arslan S, Yunus M B, Aldag J C. Fibromyalgia syndrome in rheumatoid arthritis (abstr). Arthritis Rheum, 44: S71–2001
   Google Scholar
• Middleton G D, McFarlin J E, Lipsky P E. The prevalence and clinical impact of fibromyalgia in systemic lupus erythematosus. Arthritis Rheum 1994; 37: 1181–1188
   PubMed Web of Science ®Google Scholar
• Buskila D, Press J, Abu-Shakra M. Fibromyalgia in systemic lupus erythematosus: Prevalence and clinical implications. Clin Rev Allergy Immunol 2003; 25: 25–28
   PubMed Web of Science ®Google Scholar
• Khan M A. Patient-doctor. Ann Intern Med 2000; 133: 233–235
   PubMedGoogle Scholar
• Schneiderman L J. Empathy and the literary imagination. Ann Intern Med 2002; 137: 627–629
   PubMed Web of Science ®Google Scholar
• Raingruber B, Kent M. Attending to embodied responses: A way to identify practice-based and human meanings associated with secondary trauma. Qual Health Res 2003; 13: 449–468
   PubMed Web of Science ®Google Scholar
• Spiro H M. Can reading novels make doctors more humane?. Drug Therapy 1990; 20: 15–28
   Google Scholar
• Charon R. Medicine, the novel, and the passage of time. Ann Intern Med 2000; 132: 63–68
   PubMed Web of Science ®Google Scholar
• Schneiderman H, Schneiderman R M. Literature, humanities, and the internist. Ann Intern Med 1995; 122: 618–619
   PubMed Web of Science ®Google Scholar
• Getsi L C. Intensive Care. New Rivers Press. 1992
   Google Scholar
• Yunus M B. Fibromyalgia (Complementary/Alternative Medicine). American College of Physicians, http://pier.acponline.org/physicians/alternative/camdz423/camdz423.html 10–14–2003
   Google Scholar
• Deluze C, Bosia L, Zirbs A, Chantraine A, Vischer T L. Electroacupuncture in fibromyalgia: Results of a controlled trial. BMJ 1992; 305: 1249–1252, 11–21-
   PubMed Web of Science ®Google Scholar
• Haanen H C, Hoenderdos H T, van Romunde L K, Hop W C, Mallee C, Terwiel J P, Hekster G B. Controlled trial of hypnotherapy in the treatment of refractory fibromyalgia. J Rheumatol 1991; 18: 72–75
   PubMed Web of Science ®Google Scholar
• Alfano A P, Taylor A G, Foresman P A, Dunkl P R, McConnell G G, Conaway M R, Gillies G T. Static magnetic fields for treatment of fibromyalgia: A randomized controlled trial. J Altern Complement Med 2001; 7: 53–64
   PubMed Web of Science ®Google Scholar
• Jacobsen S, Danneskiold-Samsoe B, Andersen R B. Oral S-adenosylmethionine in primary fibromyalgia. Double-blind clinical evaluation. Scand J Rheumatol 1991; 20: 294–302
   PubMed Web of Science ®Google Scholar
• Volkmann H, Norregaard J, Jacobsen S, Danneskiold-Samsoe B, Knoke G, Nehrdich D. Double-blind, placebo-controlled cross-over study of intravenous S-adenosyl-L-methionine in patients with fibromyalgia. Scand J Rheumatol 1997; 26: 206–211
   PubMed Web of Science ®Google Scholar
• McVay M R. Medicine and spirituality: A simple path to restore compassion in medicine. S D J Med 2002; 55: 487–491
   PubMedGoogle Scholar
• Nonnemaker J M, McNeely C A, Blum R W. Public and private domains of religiosity and adolescent health risk behaviors: Evidence from the National Longitudinal Study of Adolescent Health. Soc Sci Med 2003; 57: 2049–54
   PubMed Web of Science ®Google Scholar
• Lo R. The use of prayer in spiritual care. Aust J Holist Nurs 2003; 10: 22–29
   PubMedGoogle Scholar
• Berry D. Does religious psychotherapy improve anxiety and depression in religious adults? A review of the randomized controlled studies. Int J Psychiatr Nurs Res 2002; 8: 875–890
   PubMedGoogle Scholar
• Etziony M B. The Physician's Creed. Charles C. Thomas, SpringfieldIllinois, 5
   Google Scholar